Clinical Effectiveness of Intravenous Peramivir versus Oseltamivir for the Treatment of Influenza in Hospitalized Patients

References

• Puig-Barbera J, Burtseva E, Yu H, et al. Influenza epidemiology and influenza vaccine effectiveness during the 2014–2015 season: annual report from the Global Influenza Hospital surveillance network. BMC Public Health. 2016;16(Suppl 1):757. doi:10.1186/s12889-016-3378-127556802
   PubMed Web of Science ®Google Scholar
• Alame MM, Massaad E, Zaraket H. Peramivir: a novel intravenous neuraminidase inhibitor for treatment of acute influenza infections. Front Microbiol. 2016;7:450. doi:10.3389/fmicb.2016.0045027065996
   PubMed Web of Science ®Google Scholar
• McLaughlin MM, Skoglund EW, Ison MG. Peramivir: an intravenous neuraminidase inhibitor. Expert Opin Pharmacother. 2015;16(12):1889–1900. doi:10.1517/14656566.2015.106633626153242
   PubMed Web of Science ®Google Scholar
• Kohno S, Kida H, Mizuguchi M, Shimada J. Efficacy and safety of intravenous peramivir for treatment of seasonal influenza virus infection. Antimicrob Agents Chemother. 2010;54(11):4568–4574. doi:10.1128/AAC.00474-1020713668
   PubMed Web of Science ®Google Scholar
• Kohno S, Yen MY, Cheong HJ, et al. Phase III randomized, double-blind study comparing single-dose intravenous peramivir with oral oseltamivir in patients with seasonal influenza virus infection. Antimicrob Agents Chemother. 2011;55(11):5267–5276. doi:10.1128/AAC.00360-1121825298
   PubMed Web of Science ®Google Scholar
• Kohno S, Kida H, Mizuguchi M, et al. Intravenous peramivir for treatment of influenza A and B virus infection in high-risk patients. Antimicrob Agents Chemother. 2011;55(6):2803–2812. doi:10.1128/AAC.01718-1021464252
   PubMed Web of Science ®Google Scholar
• Nasu T, Ogawa D, Wada J, Makino H. Peramivir for severe influenza infection in a patient with diabetic nephropathy. Am J Respir Crit Care Med. 2010;182(9):1209–1210. doi:10.1164/ajrccm.182.9.120921041567
   PubMed Web of Science ®Google Scholar
• Huang SF, Fung CP, Perng DW, Wang FD. Effects of corticosteroid and neuraminidase inhibitors on survival in patients with respiratory distress induced by influenza virus. J Microbiol Immunol Infect. 2017;50(5):586–594. doi:10.1016/j.jmii.2015.08.01626542650
   PubMedGoogle Scholar
• Yeh CY, Wang FD, Chuang YC, et al. Clinical outcomes and prognostic factors of patients with severe influenza receiving intravenous peramivir salvage therapy in intensive care units. J Microbiol Immunol Infect. 2018;51(6):697–704. doi:10.1016/j.jmii.2017.06.00128716363
   PubMedGoogle Scholar
• Nakamura S, Miyazaki T, Izumikawa K, et al. Efficacy and safety of intravenous peramivir compared with oseltamivir in high-risk patients infected with influenza A and B viruses: a multicenter randomized controlled study. Open Forum Infect. Dis. 2017;4(3):ofx129. doi:10.1093/ofid/ofx12928761899
   PubMed Web of Science ®Google Scholar
• Yoo JW, Choi SH, Huh JW, Lim CM, Koh Y, Hong SB. Peramivir is as effective as oral oseltamivir in the treatment of severe seasonal influenza. J Med Virol. 2015;87(10):1649–1655. doi:10.1002/jmv.2423225946636
   PubMed Web of Science ®Google Scholar
• McGeer A, Green KA, Plevneshi A, et al. Antiviral therapy and outcomes of influenza requiring hospitalization in Ontario, Canada. Clin Infect Dis. 2007;45(12):1568–1575. doi:10.1086/52358418190317
   PubMed Web of Science ®Google Scholar
• Murata Y, Walsh EE, Falsey AR. Pulmonary complications of interpandemic influenza A in hospitalized adults. J Infect Dis. 2007;195(7):1029–1037. doi:10.1086/51216017330794
   PubMed Web of Science ®Google Scholar
• Walsh EE, Cox C, Falsey AR. Clinical features of influenza A virus infection in older hospitalized persons. J Am Geriatr Soc. 2002;50(9):1498–1503. doi:10.1046/j.1532-5415.2002.50404.x12383146
   PubMed Web of Science ®Google Scholar
• Lee N, Chan PK, Choi KW, et al. Factors associated with early hospital discharge of adult influenza patients. Antivir Ther. 2007;12(4):501–508.17668558
   PubMed Web of Science ®Google Scholar
• Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373–383. doi:10.1016/0021-9681(87)90171-83558716
   PubMedGoogle Scholar
• Ortiz JR, Neuzil KM, Shay DK, et al. The burden of influenza-associated critical illness hospitalizations. Crit Care Med. 2014;42(11):2325–2332. doi:10.1097/CCM.000000000000054525148596
   PubMed Web of Science ®Google Scholar
• Reed C, Chaves SS, Perez A, et al. Complications among adults hospitalized with influenza: a comparison of seasonal influenza and the 2009 H1N1 pandemic. Clin Infect Dis. 2014;59(2):166–174. doi:10.1093/cid/ciu28524785230
   PubMed Web of Science ®Google Scholar
• Birnkrant D, Cox E. The emergency use authorization of peramivir for treatment of 2009 H1N1 influenza. N Engl J Med. 2009;361(23):2204–2207. doi:10.1056/NEJMp091047919884645
   PubMed Web of Science ®Google Scholar
• Ariano RE, Sitar DS, Zelenitsky SA, et al. Enteric absorption and pharmacokinetics of oseltamivir in critically ill patients with pandemic (H1N1) influenza. CMAJ. 2010;182(4):357–363. doi:10.1503/cmaj.09212720159892
   PubMed Web of Science ®Google Scholar
• Arya V, Carter WW, Robertson SM. The role of clinical pharmacology in supporting the emergency use authorization of an unapproved anti-influenza drug, peramivir. Clin Pharmacol Ther. 2010;88(5):587–589. doi:10.1038/clpt.2010.18720959843
   PubMed Web of Science ®Google Scholar
• Ison MG, Hui DS, Clezy K, et al. A clinical trial of intravenous peramivir compared with oral oseltamivir for the treatment of seasonal influenza in hospitalized adults. Antivir Ther. 2013;18(5):651–661. doi:10.3851/IMP244223111657
   PubMed Web of Science ®Google Scholar
• Choi WS, Ryu SY, Lee J, et al. Safety and effectiveness of peramivir in Korean adult influenza patients: prospective observational study based on post-marketing surveillance data. J Korean Med Sci. 2018;33(32):e212. doi:10.3346/jkms.2018.33.e21230079005
   PubMed Web of Science ®Google Scholar
• Takemoto Y, Asai T, Ikezoe I, et al. Clinical effects of oseltamivir, zanamivir, laninamivir and peramivir on seasonal influenza infection in outpatients in Japan during the winter of 2012–2013. Chemotherapy. 2013;59(5):373–378. doi:10.1159/00036243624821568
   PubMed Web of Science ®Google Scholar
• Yoshino Y, Seo K, Koga I, Kitazawa T, Ota YJ. Clinical efficacy of peramivir in adult patients with seasonal influenza during the winter of 2012 in Japan. Clin Respir J. 2015;9(2):228–232. doi:10.1111/crj.1212924612842
   PubMed Web of Science ®Google Scholar